We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Nanobridges Transport Pro-Metastatic MicroRNAs from Cancer Cells to Surrounding Normal Tissues

By LabMedica International staff writers
Posted on 30 Dec 2015
Print article
Image: Metastatic cancer cells form nanoscale bridges with endothelial cells lining blood vessels and inject miRNA through these nanobridges to control endothelial cells (Photo courtesy of Dr. Shiladitya Sengupta, Brigham and Women\'s Hospital).
Image: Metastatic cancer cells form nanoscale bridges with endothelial cells lining blood vessels and inject miRNA through these nanobridges to control endothelial cells (Photo courtesy of Dr. Shiladitya Sengupta, Brigham and Women\'s Hospital).
Scanning electron microscope images revealed that spreading breast cancer cells generated "nanobridges" to connect to surrounding endothelial cells in order to transfect them with pro-metastatic microRNA molecules.

MicroRNAs (miRNAs) are a class of about 20 nucleotides-long RNA fragments that block gene expression by attaching to molecules of messenger RNA (mRNA) in a fashion that prevents them from transmitting the protein synthesizing instructions they had received from the DNA. With their capacity to fine-tune protein expression via sequence-specific interactions, miRNAs help regulate cell maintenance and differentiation.

While metastasis is a major cause of mortality and remains an obstacle in the search for a cure for cancer, little is known about metastatic cancer cells and endothelial cross-talk, which occurs at multiple stages during metastasis.

To better understand this process, investigators at Brigham and Women's Hospital (Boston, MA, USA) used scanning electron microscopy (SEM) techniques to observe the growth of a mixture of endothelial cells and metastatic breast cancer cells on a three-dimensional tumor matrix. They found that instead of adhering to themselves to form a sphere, the metastatic breast cancer cells spread out along the model's blood vessels. SEM revealed long, thin tubes (nanobridges) extending outward from the cancer cells to connect them to surrounding normal tissue.

Additional results published in the December 16, 2015, online edition of the journal Nature Communications revealed that contact with cancer cells caused changes in the molecular profiles of some of the normal endothelial cells. The investigators hypothesized that microRNAs were being transferred over the nanobridges into the endothelial cells, and it was found that the transformed endothelial cells had begun to express two microRNAs that had previously been implicated in metastasis.

Some chemotherapeutic agents, such as docetaxel, were shown to disrupt formation of nanobridges in treated cultures, which prevented direct communication between the tumor cells and endothelium. In mice pretreated with this class of pharmacological agent, there was a significant decrease in metastatic tumor burden.

"Metastasis remains a final frontier in the search for a cure for cancer," said senior author Dr. Shiladitya Sengupta, professor of bioengineering at Brigham and Women's Hospital. "For the past five years we have studied how cancer travels to other parts of the body, and what we find is that communication is key. Our study opens up new avenues for exploration and suggests that these nanoscale membrane bridges may represent new therapeutics in managing metastatic breast cancer. We plan to continue searching for and evaluating treatments that take aim at these conduits."

Related Links:

Brigham and Women's Hospital


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.